A Phase II Clinical Trial to Evaluate HLX208 in Advanced Melanoma Patients With BRAF V600 Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Advanced Melanoma
Related studies linked through entity extraction aliases.
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
- Status
- COMPLETED
- Phase
- N/A
A Study of GC101 TIL in Advanced Melanoma (10hospital)
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
FLX475 in Combination With Ipilimumab in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Safety, Tolerability and Pharmacokinetics of TWP-101 in Patients With Advanced Melanoma and Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Intratumoral Injection of PV-001-DV Plus DC in Patients With Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
Intratumoral Injection of Dengue Virus-1 #45AZ5 (PV-001-DV) in Patients With Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
Nab-PCE vs PC for MM After Failure of Anti-PD-1
- Status
- UNKNOWN
- Phase
- PHASE2